Benzenepropanoic acid → HCID 66761187, compound
Reaction equation
[NH:1]1[CH2:6][CH2:5][CH:4]([N:7]2[CH:11]=[C:10]([C:12]3[CH:17]=[N:16][C:15]([NH2:18])=[C:14]4[O:19][C:20]([C:22]5[C:30]6[C:25](=[CH:26][N:27]=[CH:28][CH:29]=6)[S:24][CH:23]=5)=[CH:21][C:13]=34)[CH:9]=[N:8]2)[CH2:3][CH2:2]1.C(N(C(C)C)CC)(C)C.[C:40](O)(=[O:49])[CH2:41][CH2:42][C:43]1[CH:48]=[CH:47][CH:46]=[CH:45][CH:44]=1.Cl.CN(C)CCCN=C=NCC>CN(C=O)C>[NH2:18][C:15]1[N:16]=[CH:17][C:12]([C:10]2[CH:9]=[N:8][N:7]([CH:4]3[CH2:3][CH2:2][N:1]([C:40](=[O:49])[CH2:41][CH2:42][C:43]4[CH:48]=[CH:47][CH:46]=[CH:45][CH:44]=4)[CH2:6][CH2:5]3)[CH:11]=2)=[C:13]2[CH:21]=[C:20]([C:22]3[C:30]4[C:25](=[CH:26][N:27]=[CH:28][CH:29]=4)[S:24][CH:23]=3)[O:19][C:14]=12Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of 4-(1-piperidin-4-yl-1H-pyrazol-4-yl)-2-thieno[2,3-c]pyridin-3-yl-furo[2,3-c]pyridin-7-ylamine (20.8 mg, 0.05 mmol) in DMF (0.5 mL) was added diisopropylethylamine (0.05 mL, 6.5 mmol), dihydrocinnamic acid (0.06 mmol), and N-(3-dimethylaminopropyl)-N′-ethylcarbodimide hydrochloride (13.5 mg, 0.07 mmol). The resulting solution was allowed to stir at room temperature overnight. The mixture was concentrated and then purified by MDP to afford the title compound. 1H NMR (400 MHz, CD3OD): δ 9.50 (s, 1H), 9.10 (s, 1H), 8.59 (d, J=6.1 Hz, 1H), 8.72 (d, J=6.1 Hz, 1H), 8.28 (s, 1H), 8.05 (s, 1H), 7.88 (s, 1H), 7.87 (s, 1H), 7.28 (s, 5H), 4.54 (m, 1H), 4.04 (m, 2H), 3.10 (m, 2H), 2.99 (m, 2H), 2.67 (m, 2H), 2.19 (m, 2H), 1.95 (m, 2H); MS (ESI): 549.64 [M+H]+; HPLC tR=0.86 min (HPLC: Analytical—2 min).
Workup
- concentrationThe mixture was concentrated
- custompurified by MDP
Sources & evidence
- ORD record
- ord-c9ef68f984354161a0e5891289838f3c
- Source dataset
- uspto-grants-2013_02
- Patent number
- US08378104B2
Reaction notes
Loading…